117 related articles for article (PubMed ID: 1878696)
1. Alloimmune effects of bone marrow transplantation for leukaemia on the leukaemic diseases.
Marmont AM
Bone Marrow Transplant; 1991; 7 Suppl 2():2-3. PubMed ID: 1878696
[No Abstract] [Full Text] [Related]
2. [Antonio Raichs lecture. Graft versus host disease and the graft-against-leukemia reaction. Memorial lecture].
Rozman C
Sangre (Barc); 1990 Dec; 35(6):465-73. PubMed ID: 2087666
[No Abstract] [Full Text] [Related]
3. Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.
de Witte T; Preijers F; Schattenberg A
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():103-5. PubMed ID: 2202463
[No Abstract] [Full Text] [Related]
4. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
Champlin R
Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294
[No Abstract] [Full Text] [Related]
5. How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease.
Powles R; Treleaven J; Millar J; Gordon-Smith EC; Tiley C; Findlay M; Teo C; Duncombe A; Robinson G
Bone Marrow Transplant; 1991; 7 Suppl 2():9-10. PubMed ID: 1878737
[No Abstract] [Full Text] [Related]
6. Bone marrow transplantation and graft-versus-host disease.
Powles RL
Curr Opin Immunol; 1989-1990; 2(6):870-5. PubMed ID: 2486567
[No Abstract] [Full Text] [Related]
7. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
[No Abstract] [Full Text] [Related]
8. Mixed chimerism after allogeneic bone marrow transplantation for leukemias.
Bertheas MF; Lafage M; Blaise D; Stoppa AM; Viens P; Mannoni P; Maraninchi D
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():61-3. PubMed ID: 2390641
[No Abstract] [Full Text] [Related]
9. T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias.
Aversa F; Terenzi A; Carotti A; Velardi A; Latini P; Gambelunghe C; Grignani F; Martelli MF
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():69-72. PubMed ID: 2697440
[No Abstract] [Full Text] [Related]
10. Bone marrow transplantation in Basel: single center experience from 1973 to 1989.
Speck B; Nissen C; Tichelli A; Roth J; Dazzi H; Stebler CH; Wernli M; Signer E; Gratwohl A
Clin Transpl; 1989; ():115-22. PubMed ID: 2487556
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation in the treatment of leukemia: emphasis on graft-vs-host disease and veno-occlusive disease in a Taiwan Chinese series.
Chen YC; Lin KH; Wang CH; Tang JL; Lin MT; Lui LT; Lin DT; Tien HF; Lin KS
Transplant Proc; 1992 Aug; 24(4):1526-8. PubMed ID: 1496646
[No Abstract] [Full Text] [Related]
12. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
[TBL] [Abstract][Full Text] [Related]
13. Graft versus host disease prophylaxis today.
Martelli MF; Aversa F
Bone Marrow Transplant; 1991; 7 Suppl 2():112-6. PubMed ID: 1908726
[No Abstract] [Full Text] [Related]
14. Bone marrow transplantation for leukemia: effects of T lymphocyte depletion of donor bone marrow.
Champlin R
Transplant Proc; 1987 Feb; 19(1 Pt 1):157-9. PubMed ID: 3274769
[No Abstract] [Full Text] [Related]
15. Lymphocyte depletion in bone marrow transplantation: will modulation of graft-versus-host disease prove to be superior to prevention?
Noga SJ; Hess AD
Semin Oncol; 1993 Oct; 20(5 Suppl 6):28-33. PubMed ID: 8211214
[TBL] [Abstract][Full Text] [Related]
16. HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
Storb R; Appelbaum F; Buckner CD; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():80-4. PubMed ID: 2117976
[No Abstract] [Full Text] [Related]
17. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
18. Cure after allogeneic bone marrow transplantation: chemo-radiotherapy and/or graft-versus-leukemia?
Hagenbeek A; Martens AC; Schultz FW; van Bekkum DW
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():91-3. PubMed ID: 2390645
[No Abstract] [Full Text] [Related]
19. Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.
Hansen JA; Anasetti C; Beatty PG; Martin PJ; Sanders JE; Storb R; Thomas ED
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():108-11. PubMed ID: 2390636
[No Abstract] [Full Text] [Related]
20. The reconstitution of cellular immunity after bone marrow transplantation in children.
Lanfranchi A; Porta F; Locatelli F; Zecca M; Nespoli L; Albertini A
Haematologica; 1992; 77(4):336-47. PubMed ID: 1427444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
